ICU Medical, Inc.
ICUI
NASDAQ·Healthcare·Medical - Instruments & Supplies·Mkt cap $4.2B
$167.58
▲ +0.78%
P/E
139.65
Mkt Cap
$4.2B
52-Wk Range
$112.50–$192.85
52-Week Range
$112.50 - $192.85
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 28.3% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
5 reasons
- Proprietary needlefree and closed-system technology reducing infection rates and improving patient safety
- Integrated MedNet software platform creating switching costs and deepening hospital relationships
- Comprehensive product portfolio addressing multiple clinical needs within infusion and critical care
- Established distribution channels and long-term relationships with major hospital systems and healthcare networks
- Strong intellectual property portfolio protecting core innovations in connector and safety technologies
Bear Case
1 risk
- Low volatility (beta 0.8).
Growth
Stable outlook
Growing mid-cap in Medical - Instruments & Supplies
Value
Fairly valued vs Medical Devices peers
Momentum
Hot
+21.9% over 3m
Quality
Stable
Strong fundamentals
Dividend
None
No dividend
Smart-money signal
Who's buying ICUI right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 5, 2026
AUG 6, 2026
Reported EPS of $2.37 vs $1.91 consensus (+24.1% surprise). Revenue of $547.9M vs $533.4M expected (+2.7%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+24.1%
Revenue trend · last 8Q
—
+7%
+7%
-8%
-9%
-14%
-12%
+0%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$589.1M
$629.8M
$604.7M
$548.9M
$537.0M
$540.3M
$530.4M
$551.5M
Margins · last 8Q
Gross
48.6%
Operating
7.1%
Profit
-7.0%
Wall Street consensus
6 analysts · 83% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
83%
Hold
17%
Sell
0%
Median Price Target
—
Latest: BTIG · Aug 7, 2026
vs Industry
How ICUI stacks vs Medical - Instruments & Supplies
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related